Up to 2014, within the scope of the European project "Electronic Health Records for Clinical Research" (EHR4CR), partners from academic research and industry will be jointly establishing a Europe-wide technology platform that aims to allow secondary use of data from electronic health records for the purpose of clinical research.
Today, lawyers, ethics specialists, and data protection experts from various EU member states are discussing in Berlin what legal and ethical issues will have to be addressed. The workshop is being organized by TMF, which – due to its extensive preliminary work on data protection and ethical issues of networked medical research – in this project is leading a work package dealing with the topic of data protection and data security.
Secondary use of data from electronic health records for the purpose of medical research could cut costs, speed up clinical research projects and make them more efficient. In particular, researchers could better identify suitable study patients – hitherto one of the major difficulties in planning and conducting clinical studies. Now a technological platform is to be created which will seamlessly integrate electronic health records into existing research platforms and networks in the health sector.
Legal Regulations in the EU Countries Vary Considerably
However, many legal and ethical issues still have to be clarified on the way. In particular, one of the reasons why the legal framework to which physicians, researchers and patients are exposed in the cross-border use of patient data for clinical research is uncertain is that the legal regulations and implemented legal practice concerning data protection and protection of the private domain vary substantially throughout the individual EU member states. For this reason, one work package in the EHR4CR project has the task of analyzing the current legal situations in the various member states of the EU and comparing them with one another. The aim is to provide recommendations as to how legal certainty can be created for clinical research when using the EU-wide technology platform.
At the workshop in Berlin on January 12 and 13, 2012, the legal situation in selected pilot countries is being presented: France, Great Britain, Scotland, and Germany. European researchers, lawyers and data protectionists will be jointly examining what points on the pathway of data from clinics to research are critical in legal terms.
One of the Largest Public-Private Partnership Projects in Europe
The EHR4CR project is being funded with a total of 17 million euros within the scope of the Innovative Medicines Initiative (IMI) over the period from 2011 to 2014. IMI is one of the largest public-private partnership projects in Europe with the aim of speeding up the development of better and safer medicinal drugs. The initiative is being jointly funded by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Bio-based films suitable for industrial use
08.06.2015 | Fraunhofer-Institut für Angewandte Polymerforschung IAP
EMBO-Workshop on SMC proteins at the IMP Vienna
12.05.2015 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH
Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.
The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...
New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions
A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...
Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.
Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...
A team of scientists including PhD student Friedrich Schuler from the Laboratory of MEMS Applications at the Department of Microsystems Engineering (IMTEK) of...
The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of...
25.06.2015 | Event News
16.06.2015 | Event News
11.06.2015 | Event News
03.07.2015 | Press release
03.07.2015 | Agricultural and Forestry Science
03.07.2015 | Health and Medicine